Veterinary Medicines

ADE – vit injekčný roztok

Authorised
  • RETINOL ACETATE
  • Ergocalciferol
  • ALPHATOCOPHEROL ACETATE
Download as PDF

Product identification

Medicine name:
ADE – vit injekčný roztok
Active substance:
  • RETINOL ACETATE
  • Ergocalciferol
  • ALPHATOCOPHEROL ACETATE
Target species:
  • Cattle
  • Horse
  • Pig
  • Sheep
  • Goat
  • Rabbit
  • Dog
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • RETINOL ACETATE
    100000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Ergocalciferol
    100000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • ALPHATOCOPHEROL ACETATE
    30.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
    • Horse
    • Pig
    • Sheep
    • Goat
    • Rabbit
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11CB
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • USKVBL
Authorisation number:
  • 96/009/03-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 9/08/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."